SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Beryl Drugs

Beryl Drugs

BSE: 524606 | NSE: | ISIN: INE415H01017 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Nov 13, 17:05
32.35
0.70 (+2.21%)
VOLUME 103,706
AVERAGE VOLUME
5-Day 123,901
10-Day 113,511
30-Day 85,962
VOLUME SHOCKER
5-Day 123,901
10-Day 113,511
30-Day 85,962
Prev. Close
31.65
Open Price
33.25
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 30.75 33.30
52 Wk Low/High 18.95 48.00

Beryl Drugs is not listed on NSE

Action in Beryl Drugs

No recommendations so far.

What's your call on Beryl Drugs today?
Read Investor view

MARKET CAP (Rs Cr)
16.41
*P/E
57.77
*BOOK VALUE (Rs)
12.62
DIV (%)
0.00%
Market Lot
1
INDUSTRY P/E
24.35
*EPS (TTM)
0.56
*P/C
27.18
*PRICE/BOOK
2.56
DIV YIELD.(%)
-%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
40.27 new
DELIVERY AVERAGES
3-Day 48.87%
5-Day 45.56%
8-Day 48.77%
* Based on standalone numbers
Track Beryl Drugs on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

19 November 2014

buy

Glenmark Nov Fut

Entry Price (Rs)

812.50

Exit Price (Rs)

824.50

Gain (Rs)

12.00

sell

RelCapital Nov Fut

Entry Price (Rs)

516.85

Exit Price (Rs)

509.00

Gain (Rs)

8.00

sell

Cipla Nov Fut

Entry Price (Rs)

606.30

Exit Price (Rs)

598.30

Gain (Rs)

8.00

buy

HavellsIndia Nov Fut

Entry Price (Rs)

312.00

Exit Price (Rs)

316.65

Gain (Rs)

5.00

buy

ZeeEntertain Nov Fut

Entry Price (Rs)

385.00

Exit Price (Rs)

388.90

Gain (Rs)

4.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 24.00 33.25  
High Price 25.95 33.30  
Low Price 23.10 30.75  
Last Price 24.15 32.35 33.95
Volume 39,640 103,706 161.62
Simple Moving Averages
Days BSE NSE
30 31.01
50 30.32
150 27.70
200 28.89

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Beryl Drugs

News/Videos & Announcements
Stock Advice & Research Reports
Stock Advice
No Advice
Research Reports
No Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
 Standalone (Sep '14)
(Jun '14)
Net Sales 3.33 3.65
Other Income 0.02 0.01
PBDIT 0.33 0.23
Net Profit 0.15 0.07

Annual Report

Download in PDF format 2014 |2013 |2012 |2011 |2010
Balance Sheet
(Jun '14)
(In Rs Cr)
Total Share Capital 5.09
Net Worth 6.42
Total Debt 1.53
Net Block 2.80
Investments 0.73
Net Current Assets 4.29
Total Assets 7.95
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 851.10 0.13 932.00 552.50 176,276.76
Lupin 1469.15 1.38 1472.00 841.10 65,970.95
Dr Reddys Labs 3519.25 0.13 3565.00 2250.00 59,956.00
Cipla 618.60 3.23 671.95 366.70 49,668.72
Aurobindo Pharm 1129.65 0.53 1151.70 279.35 32,925.31
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Sep' 14Jun' 14Mar' 14Dec' 13
Promoter24.9224.7424.9225.03
FII0.000.000.000.00
DII0.000.000.000.00
Others75.0875.2675.0874.97
Total100.00100.00100.00100.00
Mutual Funds Holding
No Mutual Funds Holding the share
Company Information
REGISTERED OFFICE
Address
133, Kanchan Bag ,
City
Indore
State
Madhya Pradesh
Pin Code
452001
Tel. No.
0731-25076375
Fax No.
0731-25065375
REGISTRARS
Name
Adroit Corporate Service (P) Ltd.
Address
No.19/20, Jafferbhoy Industrial Estate, 1st Floor,Makwana Road, Marol Naka, Andheri (East)
City
Mumbai - 400059
State
Maharashtra
Tel. No.
022-42270400, 28596060, 28594060
Fax No.
022-28503748, 66924438
MANAGEMENT
Name
Designation
Sanjay Sethi
Chairman & Managing Director
Sudhir Sethi
Whole Time Director
Sunil Jain
Director
Hemant Jain
Director
Avinash Sharma
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

DCB Bank Recommended on Aug 19th 2014

Recommended price 81.00  |  Peak from reco 107.05 31.51%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Beryl Drugs

Beryl Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 16.41 crore.The company has reported a standalone sales of Rs 3.33 crore and a Net Profit of Rs 0.15 crore for the quarter ended Sep 2014.

The company management includes Sanjay Sethi - Chairman & Managing Director, Sudhir Sethi - Whole Time Director, Sunil Jain - Director, Hemant Jain - Director, Avinash Sharma - Director, Bagachand Jain - Director.

It is listed on the BSE with a BSE Code of 524606.

Its Registered office is at 133, Kanchan Bag , Indore,Madhya Pradesh - 452001.

Their Registrars are Adroit Corporate Service (P) Ltd.

Quick Links for Beryl Drugs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Beryl Drugs